NCT07776093

Brief Summary

The purpose of this study is to compare the effects of manual therapy and a multicomponent exercise program on suboccipital muscle thickness, joint position sense, pain, central sensitization, balance, and kinesiophobia in patients diagnosed with cervicogenic headache. Cervicogenic headache is a common secondary headache originating from dysfunction in the upper cervical spine. Dysfunction in the deep neck muscles, impaired neck joint awareness, and heightened pain sensitivity (central sensitization) are frequently observed in these patients. While both manual therapy and targeted exercise are used in physiotherapy practice, evidence regarding their direct comparative effects on suboccipital muscle morphology and somatosensory parameters remains limited. Participants will be randomly assigned to one of two treatment groups for a duration of 4 weeks (12 sessions total):

  • Do manual therapy and multicomponent exercise improve suboccipital muscle thickness and cervical joint position sense in patients with cervicogenic headache?
  • Is there a significant difference between manual therapy and multicomponent exercise in reducing pain intensity, central sensitization, disability, and fear of movement (kinesiophobia)? It is hypothesized that both intervention protocols will yield significant clinical improvements, with specific synergistic adaptations in muscle structure, somatosensory system processing, and pain-related fear.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Sep 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 20, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2027

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

August 24, 2026

Status Verified

August 1, 2026

Enrollment Period

6 months

First QC Date

August 17, 2026

Last Update Submit

August 20, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change from Baseline Pain Intensity

    Evaluated using a 10-cm Visual Analog Scale (VAS) measured in centimeters to assess headache pain intensity.

    Baseline and Post-intervention (Week 4)

  • Change from Baseline Central Sensitization Inventory Score

    Assessed using the 25-item Central Sensitization Inventory (CSI) with a total score ranging from 0 to 100 to evaluate the severity of central sensitization.

    Baseline and Post-intervention at 4 Weeks

  • Change from Baseline Tampa Scale for Kinesiophobia Score

    Evaluated using the Tampa Scale for Kinesiophobia (TSK) 4-point Likert scale (17-68 score range) to measure fear of movement and re-injury.

    Baseline and Post-intervention at Week 4

  • Change from Baseline Migraine Disability Assessment Score

    Assessed using the 5-item Migraine Disability Assessment (MIDAS) questionnaire to evaluate the total number of days with headache-related disability (score range 0 to 21+ for disability severity grades I to IV)

    Baseline and Post-intervention at 4 Weeks.

  • Change from Baseline Neck Disability Index Score

    Evaluated using the 10-item Neck Disability Index (NDI) questionnaire to measure neck pain-related functional disability (score range 0 to 50, higher scores indicating higher disability).

    Baseline and Post-intervention at 4 Weeks

Secondary Outcomes (6)

  • Change from Baseline Suboccipital Muscle Thickness

    Baseline and Post-intervention at 4 Weeks

  • Change from Baseline Cervical Joint Position Sense Error

    Baseline and Post-intervention at 4 Weeks

  • Change from Baseline Head-Eye Movement Control Test Score

    Baseline and Post-intervention at Week 4

  • Change from Baseline Deep Cervical Flexor Muscle Endurance

    Baseline and Post-intervention (Week 4).

  • Change from Baseline Postural Balance Score

    Baseline and Post-intervention at Week 4

  • +1 more secondary outcomes

Study Arms (2)

Manual Therapy Group

EXPERIMENTAL

Participants in this arm will receive 12 sessions of manual therapy (3 sessions per week for 4 weeks). Interventions include upper cervical joint mobilization, myofascial release, suboccipital distraction, and trigger point therapy targeting the suboccipital and cervical region.

Procedure: Manual Therapy Protocol

Multicomponent Exercise Group

ACTIVE COMPARATOR

Participants in this arm will receive 12 sessions of a multicomponent exercise program (3 sessions per week for 4 weeks). Interventions include deep cervical flexor strengthening, cervical proprioception training, gaze stability/head-eye coordination exercises, and progressive postural balance training.

Other: Multicomponent Exercise Program

Interventions

Upper cervical joint mobilization, myofascial release, suboccipital distraction, and trigger point therapy targeting the cervical region.

Manual Therapy Group

Deep cervical flexor strengthening, cervical proprioception exercises, gaze stability/head-eye coordination training, and progressive balance exercises.

Multicomponent Exercise Group

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of cervicogenic headache by a specialist physician,
  • Aged between 18 and 45 years,
  • Ability to read and write (literate),
  • Provision of signed informed consent to participate in the study.

You may not qualify if:

  • History of head or neck surgery,
  • History of spinal surgery,
  • History of severe cardiac conditions or cardiac surgery that contraindicates exercise,
  • History of ongoing or past malignancy,
  • Diagnosis of psychiatric disorders,
  • Diagnosis of migraine,
  • Diagnosis of fibromyalgia,
  • Having received medical (except analgesics), physical therapy, or other interventions (e.g., alternative medicine, massage therapy) for cervicogenic headache within the last 6 months,
  • Engaging in regular exercise or attending an exercise facility within the last 6 months,
  • Experiencing headaches strictly associated with the menstrual period,
  • Communication problems interfering with evaluation and treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Post-Traumatic HeadacheSomatosensory Disorders

Condition Hierarchy (Ancestors)

Headache Disorders, SecondaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesSensation DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
This study will employ a double-blind design. Participants will be masked regarding their group allocation (manual therapy vs. multicomponent exercise). All baseline and post-intervention outcome assessments will be conducted by an independent outcome assessor who will be fully blinded to the participants' group assignments and intervention protocols. The student physiotherapists administering the treatment protocols will be blinded to all evaluation and assessment results to prevent operator bias.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

August 17, 2026

First Posted

August 20, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

March 31, 2027

Last Updated

August 24, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share